The emergency green light was given for casirivimab and imdevimab, two monoclonal antibodies developed by Regeneron Pharmaceuticals, to be administered to children above the age of 12 and adults, including those over 65 with underlying health conditions, as part of a therapy to stop their condition from worsening. Justifying the …
Read More »FDA grants emergency use authorization for experimental Regeneron Covid-19 cocktail given to Trump
